This talk will discuss aspects of the clinically validated next generation sequencing assay Rapid Heme Panel version 3 (RHPv3) and ongoing development of version 4 (RHPv4) through a longstanding collaboration between the Center for Advanced Molecular Diagnostics at Brigham and Women’s Hospital and New England Biolabs.
